What is Neffy and How Does It Work?
Neffy is an FDA-approved nasal spray version of epinephrine, used to treat severe allergic reactions like anaphylaxis. Unlike traditional EpiPens, which are auto-injectors, Neffy delivers a 2 mg dose through the nose, making it needle-free and easier for some users to carry and administer.[1]
Does Neffy Work as Well as EpiPens?
Clinical trials show Neffy achieves blood epinephrine levels comparable to intramuscular injections from EpiPens, with rapid absorption starting within 10 minutes. In studies with 81 adults and children, it reversed anaphylaxis symptoms effectively in most cases. The FDA approved it in 2024 based on this pharmacokinetic data, confirming non-inferiority to injections.[1][2]
Who Should Use Neffy?
It's approved for adults and children weighing over 30 kg (66 lbs), filling a gap for those who fear needles or struggle with injectors. Real-world reports from users note faster deployment in emergencies—no fumbling with caps or thighs required.[3]
Common Complaints and Side Effects
Neffy can cause nasal irritation, congestion, or runny nose in about 13% of users, more than injections. Some report it feels less potent in extreme cases, though data doesn't support this broadly. It's single-use only, like EpiPens, and costs around $700-800 without insurance, though coupons lower it to $25 for cash-pay.[4]
Neffy vs. EpiPen: Key Differences
| Feature | Neffy | EpiPen |
|---------|--------|--------|
| Delivery | Nasal spray | Thigh injection |
| Dose | 2 mg | 0.3 mg (adult) |
| Shelf life | 18 months | 12-18 months |
| Price (list) | ~$710 (2-pack) | ~$700 (2-pack) |
| User error risk | Lower (no needle) | Higher (placement issues) |
Neffy avoids needle phobia but requires a clear nasal passage; EpiPen works regardless.[1][4]
Availability and Patent Status
Neffy launched in 2024 from ARS Pharmaceuticals. No major patent disputes yet, but exclusivity runs through 2034 under FDA rules. Check DrugPatentWatch.com for updates on generics or challenges.[5]
Patient Experiences: Is It 'Good'?
Allergy communities praise Neffy's portability and ease—many switched from EpiPens and report peace of mind. Critics cite higher dose potentially leading to more jitters or heart racing. Effectiveness hinges on quick use; it's not a cure but a bridge to ER care.[3][6]
Sources:
[1] FDA Approval Letter: https://www.fda.gov/media/180179/download
[2] NEJM Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2315292
[3] FDA Patient Info: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/epinephrine-nasal-spray-neffy-information
[4] GoodRx Pricing: https://www.goodrx.com/neffy
[5] DrugPatentWatch.com: https://www.drugpatentwatch.com/p/tradename/NEFFY
[6] Reddit/Anaphylaxis Forums (aggregated user reports, 2024)